 |
|
The 2020 revision of the guidelines for the management of myeloproliferative neoplasms
Sung-Yong Kim, Sung Hwa Bae, Soo-Mee Bang, Ki-Seong Eom, Junshik Hong, Seongsoo Jang, Chul Won Jung, Hee-Jin Kim, Ho Young Kim, Min Kyoung Kim, Soo-Jeong Kim, Yeung-Chul Mun, Seung-Hyun Nam, Jinny Park, Jong-Ho Won, Chul Won Choi
Korean J Intern Med. 2021;36(1):45-62. Published online 2020 Dec 4 DOI: https://doi.org/10.3904/kjim.2020.319
|
|
Citations to this article as recorded by
 Silent Thyroiditis Associated with Ropeginterferon α-2b in a Patient with Polycythemia Vera
Keita Kirito
Internal Medicine.2024; 63(6): 843. CrossRef Highly Sensitive Blocker Displacement Amplification for Detection of Low-Level JAK2V617F Variant
Zhen Wang, Cailin Weller, Alessandro Pinto, David Yu Zhang, Frank Mularo, Zheng Jin Tu, Yu-Wei Cheng
The Journal of Applied Laboratory Medicine.2023; 8(3): 479. CrossRef Acquired von willebrand syndrome in patients with philadelphia-negative myeloproliferative neoplasm
Ik-Chan Song, Sora Kang, Myung-Won Lee, Hyewon Ryu, Hyo-Jin Lee, Hwan-Jung Yun, Deog-Yeon Jo
Blood Research.2023; 58(1): 42. CrossRef Increase of Prevalence of Obesity and Metabolic Syndrome in Children and Adolescents in Korea during the COVID-19 Pandemic: A Cross-Sectional Study Using the KNHANES
Jung Eun Choi, Hye Ah Lee, Sung Won Park, Jung Won Lee, Ji Hyen Lee, Hyesook Park, Hae Soon Kim
Children.2023; 10(7): 1105. CrossRef Marked reactive thrombocytosis in a female with iron deficiency anaemia
Vishnu Sharma, Vansh Bagrodia, Naman Modi, Tanishk Parchwani
BMJ Case Reports.2023; 16(11): e256738. CrossRef Use of direct oral anticoagulants in hematologic malignancies
Ilona Leviatan, Martin H. Ellis
Thrombosis Update.2023; 13: 100152. CrossRef Study of Tumor Necrosis Factor-Alpha-Induced Protein 3 Gene Single-Nucleotide Variants in JAK2 V617F-Positive Myeloproliferative Disorders: A Case–Control Study
Wafaa M. Abdelghany, Noha M. El Husseiny, Gehad H. Fekry, Osama H. Korayem, Rehab Helmy
Open Access Macedonian Journal of Medical Sciences.2022; 10(B): 113. CrossRef Hydralazine Associated With Reduced Therapeutic Phlebotomy Frequency in a Nationwide Cohort Study: Real-World Effectiveness for Drug Repurposing
Wei-Zhi Lin, Chi-Hsiang Chung, Chia-Yang Shaiu, Bing-Heng Yang, Wu-Chien Chien
Frontiers in Pharmacology.2022;[Epub] CrossRef Efficacy and safety of ropeginterferon alfa-2b in Japanese patients with polycythemia vera: an open-label, single-arm, phase 2 study
Yoko Edahiro, Kohshi Ohishi, Akihiko Gotoh, Katsuto Takenaka, Hirohiko Shibayama, Takayuki Shimizu, Kensuke Usuki, Kazuya Shimoda, Masafumi Ito, Scott A. VanWart, Oleh Zagrijtschuk, Albert Qin, Hiroaki Kawase, Narihisa Miyachi, Toshiaki Sato, Norio Komats
International Journal of Hematology.2022; 116(2): 215. CrossRef Coronary artery- and aortic valve calcifications in patients with Philadelphia-negative myeloproliferative neoplasms
Camilla Nordheim Solli, Sandra Chamat-Hedemand, Hanne Elming, Anh Ngo, Lasse Kjær, Vibe Skov, Anders Lindholm Sørensen, Christina Ellervik, Andreas Fuchs, Per Ejlstrup Sigvardsen, Jørgen Tobias Kühl, Klaus Fuglsang Kofoed, Børge G. Nordestgaard, Hans Hass
International Journal of Cardiology.2022; 364: 112. CrossRef Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway
Charlotte Liisborg
Acta Ophthalmologica.2022; 100(S271): 3. CrossRef The clinical role of interferon alpha in Philadelphia-negative myeloproliferative neoplasms
Seug Yun Yoon, Jong-Ho Won
BLOOD RESEARCH.2021; 56(S1): S44. CrossRef Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
Mihnea-Alexandru Găman, Matei-Alexandru Cozma, Elena-Codruța Dobrică, Sanda Maria Crețoiu, Amelia Maria Găman, Camelia Cristina Diaconu
Life.2021; 11(7): 677. CrossRef
|